Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 2315 Neoplasms 1678 Prostatic Neoplasms 1178 Lung Neoplasms 908 Colorectal Neoplasms 873 Carcinoma, Non-Small-Cell Lung 848 Leukemia, Myeloid, Acute 587 Pancreatic Neoplasms 568 Multiple Myeloma 542 Carcinoma, Hepatocellular 510 Brain Neoplasms 509 Neoplasm Metastasis 456 Head and Neck Neoplasms 454 Melanoma 410 Ovarian Neoplasms 404 Glioblastoma 397 Precursor Cell Lymphoblastic Leukemia-Lymphoma 390 Stomach Neoplasms 370 Uterine Cervical Neoplasms 355 Squamous Cell Carcinoma of Head and Neck 355 Rectal Neoplasms 336 Recurrence 332 Hematologic Neoplasms 323 Sarcoma 322 Colonic Neoplasms 316 Lymphoma 310 Triple Negative Breast Neoplasms 284 Urinary Bladder Neoplasms 279 Glioma 277 Carcinoma, Renal Cell 277

Interventions

Dexmedetomidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Opioid Consumption, Postoperative × 1 year × Clear all

NCT07263165 2025-12-04

Dexmedetomidin

Assiut University

Phase NA Not yet recruiting

Opioid Consumption, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡